PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Product Development Division, LucasBio Co., Ltd., Seoul, South Korea.\', \'Division of Respiratory, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary\'s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.\', \'Department of Laboratory Medicine, Seoul St. Mary\'s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.\', \'Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea.\', \'Institute for Translational Research and Molecular Imaging, The Catholic University of Korea, Seoul, South Korea.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.751869
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35003063
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35003063>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35003063>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all